ECSP055997A - Vacuna de vibrio cholerae inactivada en tabletas - Google Patents

Vacuna de vibrio cholerae inactivada en tabletas

Info

Publication number
ECSP055997A
ECSP055997A EC2005005997A ECSP055997A ECSP055997A EC SP055997 A ECSP055997 A EC SP055997A EC 2005005997 A EC2005005997 A EC 2005005997A EC SP055997 A ECSP055997 A EC SP055997A EC SP055997 A ECSP055997 A EC SP055997A
Authority
EC
Ecuador
Prior art keywords
vibrio cholerae
vaccine
inactivated
tablets
vaccines
Prior art date
Application number
EC2005005997A
Other languages
English (en)
Inventor
Coronel Arturo Talavera
Lopez Gemma Ano
Fernandez Jorge Luis Castano
Hernandez Evangelina Urribarri
Perez Tania Balmaseda
Marrero Barbara Cedre
Imia Luis Garcia
Quinoy Jose Luis Perez
Suarez Caridad Torres
Navarro Yadira Pino
Sanchez Hilda Maria Garcia
Original Assignee
Inst Finlay Ct De Investigacio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacio filed Critical Inst Finlay Ct De Investigacio
Publication of ECSP055997A publication Critical patent/ECSP055997A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/106Vibrio; Campylobacter; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con el campo de las vacunas, específicamente con las vacunas de aplicación oral contra el cólera. El objetivo técnico que persigue es obtener una formulación en tabletas de vacunas de células enteras inactivadas de Vibrio cholerae. La invención describe la formulación del producto vacunal.
EC2005005997A 2003-03-20 2005-09-02 Vacuna de vibrio cholerae inactivada en tabletas ECSP055997A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030061A CU23334A1 (es) 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas

Publications (1)

Publication Number Publication Date
ECSP055997A true ECSP055997A (es) 2006-01-27

Family

ID=40203015

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005997A ECSP055997A (es) 2003-03-20 2005-09-02 Vacuna de vibrio cholerae inactivada en tabletas

Country Status (13)

Country Link
US (1) US20060246094A1 (es)
EP (1) EP1614427A1 (es)
JP (1) JP2006520332A (es)
KR (1) KR20050109978A (es)
CN (1) CN1791426A (es)
AR (1) AR043621A1 (es)
BR (1) BRPI0408409A (es)
CA (1) CA2519225A1 (es)
CU (1) CU23334A1 (es)
EC (1) ECSP055997A (es)
PE (1) PE20041064A1 (es)
WO (1) WO2004082711A1 (es)
ZA (1) ZA200507576B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2477649T3 (pl) * 2009-09-16 2017-06-30 Msd Wellcome Trust Hilleman Laboratories Pvt Ltd. Szczepionka przeciwko biegunce powodowanej przez cholerę i enterotoksynogenną e. coli (etec)
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
US6203799B1 (en) * 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit

Also Published As

Publication number Publication date
CN1791426A (zh) 2006-06-21
US20060246094A1 (en) 2006-11-02
EP1614427A1 (en) 2006-01-11
AR043621A1 (es) 2005-08-03
ZA200507576B (en) 2007-01-31
CA2519225A1 (en) 2004-09-30
WO2004082711A1 (es) 2004-09-30
BRPI0408409A (pt) 2006-03-21
PE20041064A1 (es) 2005-03-02
CU23334A1 (es) 2008-12-24
KR20050109978A (ko) 2005-11-22
JP2006520332A (ja) 2006-09-07

Similar Documents

Publication Publication Date Title
CL2019000209A1 (es) Formulación novedosa administrable por la vía oral.
MX2012005365A (es) Formulaciones de tableta de liberacion inmediata.
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
UY31350A1 (es) (carboxilalquilenfenil)feniloxamidas, procedimiento para su preparación y su utilización como medicamentos
CR8569A (es) Inhibidores de integrasa de vih
ECSP10010295A (es) Formulacion de anticuerpo
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY32240A (es) Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
UY32190A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibdores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales
UA99645C2 (ru) Гель, имеющий противовоспалительное и противоаллергическое действие
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
NO20084478L (no) Konjugerte lipidderivater
CL2010000281A1 (es) Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion.
CO6420389A2 (es) Composiciones y métodos para el tratamiento y prevención de la enfermedad cardiovascular
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
GT200800235A (es) Formulacion de medicamento liquida
UY29065A1 (es) Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos.
MX2009012713A (es) Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas.
ECSP055997A (es) Vacuna de vibrio cholerae inactivada en tabletas
ATE534382T1 (de) Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
RU2009107155A (ru) Антиоксидантное лекарственное средство на основе спиртовых отходов